Fu Yang-Yang, Li Wen-Mao, Cai Hong-Qiao, Jiao Yan
Department of The First Operation Room, The First Hospital of Jilin University, Changchun 130000, Jilin Province, China.
Department of Rehabilitation, The Second Hospital of Jilin University, Changchun 130000, Jilin Province, China.
World J Gastrointest Surg. 2024 Dec 27;16(12):3903-3906. doi: 10.4240/wjgs.v16.i12.3903.
This article discusses the article written by Tan . Transarterial chemoembolization (TACE) is one of the main treatment methods for advanced hepatocellular carcinoma (HCC). There are other vascular interventional therapies, including drug-eluting bead TACE, transarterial radioembolization, and hepatic arterial infusion chemotherapy. TACE combined with anti-angiogenesis therapy may improve tumor control and prolong progression free survival. The combination therapy of TACE and immunotherapy may improve the clinical efficacy of HCC. In future research, more basic and clinical studies are needed to explore the immunogenic intervention therapy.
本文讨论了谭所撰写的文章。经动脉化疗栓塞术（TACE）是晚期肝细胞癌（HCC）的主要治疗方法之一。还有其他血管介入治疗方法，包括载药微球TACE、经动脉放射性栓塞术和肝动脉灌注化疗。TACE联合抗血管生成治疗可能会改善肿瘤控制并延长无进展生存期。TACE与免疫治疗的联合疗法可能会提高HCC的临床疗效。在未来的研究中，需要更多的基础和临床研究来探索免疫原性干预疗法。
